A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer
RNA-seq (gene expression) · human · 32 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Breast cancerThis series is part of our curated briefing on it.
- Samples
- 32 samples: 14 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE264630_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1103684 and SRA study SRP503532. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 30 samples.
How we read this: 14 replicated groups read from 32 sample titles; they account for 30 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8224240 PDX model, LLY283_1 PDX model, LLY283
- GSM8224241 PDX model, LLY283_2 PDX model, LLY283
- GSM8224242 PDX model, LLY283_3 PDX model, LLY283
- GSM8224243 PDX model, control_1 PDX model, control
- GSM8224244 PDX model, control_2 PDX model, control
- GSM8224245 PDX model, control_3 PDX model, control
- GSM8224246 MDA-MB-436 cells, DMSO_1 MDA-MB-436 cells, DMSO
- GSM8224247 MDA-MB-436-20RC cells, DMSO_1 MDA-MB-436-20RC cells, …
- GSM8224248 MDA-MB-436-20RC cells,GSK591_1 MDA-MB-436-20RC cells,G…
- GSM8224249 MDA-MB-436-20RC cells, LLY283_1 MDA-MB-436-20RC cells, …
- GSM8224250 MDA-MB-436 cells, DMSO_2 MDA-MB-436 cells, DMSO
- GSM8224251 MDA-MB-436 cells, GSK591_1 MDA-MB-436 cells, GSK591
- GSM8224252 MDA-MB-436 cells, LLY283_1 MDA-MB-436 cells, LLY283
- GSM8224253 MDA-MB-436-20RA cells, DMSO_1 MDA-MB-436-20RA cells, …
- GSM8224254 MDA-MB-436-20RA cells,GSK591_1 MDA-MB-436-20RA cells,G…
- GSM8224255 MDA-MB-436-20RA cells, LLY283_1 MDA-MB-436-20RA cells, …
- GSM8224256 MDA-MB-436-20RB cells, DMSO_1 MDA-MB-436-20RB cells, …
- GSM8224257 MDA-MB-436 cells, GSK591_2 MDA-MB-436 cells, GSK591
- GSM8224258 MDA-MB-436-20RB cells,GSK591_1 MDA-MB-436-20RB cells,G…
- GSM8224259 MDA-MB-436-20RB cells, LLY283_1 MDA-MB-436-20RB cells, …
- GSM8224260 MDA-MB-436-20RC cells, DMSO_2 MDA-MB-436-20RC cells, …
- GSM8224261 MDA-MB-436-20RC cells,GSK591_2 MDA-MB-436-20RC cells,G…
- GSM8224262 MDA-MB-436-20RC cells, LLY283_2 MDA-MB-436-20RC cells, …
- GSM8224263 Hs 578T-20RA cells, DMSO_1
- GSM8224264 MDA-MB-436 cells, LLY283_2 MDA-MB-436 cells, LLY283
- GSM8224265 Hs 579T-20RA cells, LLY283_1
- GSM8224266 MDA-MB-436-20RA cells, DMSO_2 MDA-MB-436-20RA cells, …
- GSM8224267 MDA-MB-436-20RA cells,GSK591_2 MDA-MB-436-20RA cells,G…
- GSM8224268 MDA-MB-436-20RA cells, LLY283_2 MDA-MB-436-20RA cells, …
- GSM8224269 MDA-MB-436-20RB cells, DMSO_2 MDA-MB-436-20RB cells, …
- GSM8224270 MDA-MB-436-20RB cells,GSK591_2 MDA-MB-436-20RB cells,G…
- GSM8224271 MDA-MB-436-20RB cells, LLY283_2 MDA-MB-436-20RB cells, …
- GSE104193 Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signalling and malignant features in vitro and in vivo 32 samples same disease briefing
- GSE104675 Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6 samples same disease briefing
- GSE10885 An integromic analysis reveals that metaplastic carcinomas are distinct from basal-like tumors. 244 samples same disease briefing
- GSE10886 A Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes 226 samples same disease briefing
- GSE11121 The humoral immune system has a key prognostic impact in node-negative breast cancer 200 samples same disease briefing
- GSE313741 A covalent fragment screen identifies ferroptosis induced by GPX4 inhibition as a vulnerability of senescent cells [PC3] 25 samples shares vulnerability, identifies, screen
- GSE305958 CRISPR Screens Identify the ATPase VCP as a Druggable Therapeutic Vulnerability in Cholangiocarcinoma 14 samples shares vulnerability, therapeutic, screen
- GSE307575 A covalent fragment screen identifies ferroptosis induced by GPX4 inhibition as a vulnerability of senescent cells 11 samples shares vulnerability, identifies, screen
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.